The future of healthcare systems. Method for rigorously assessing cost effectiveness of new drugs must be set up
BMJ
.
1997 Oct 11;315(7113):953.
Authors
P Milner
,
K Walshe
,
A Lipp
,
R Milne
PMID:
9361566
PMCID:
PMC2127630
No abstract available
Publication types
Letter
Comment
MeSH terms
Cost-Benefit Analysis
Delivery of Health Care / trends*
Drug Costs*
Forecasting
Humans
State Medicine / trends
United Kingdom